Learning Basic Science Concepts — clinical cases
29 questions
Sample cases
- Case 1
A 38-year-old man maintained on methadone 90 mg daily for opioid use disorder wants to switch to buprenorphine–naloxone. Against advice he takes an 8 mg/2 mg sublingual dose 6 hours after his usual methadone dose and, within an hour, develops yawning, rhinorrhea, piloerection, abdominal cramps and agitation.
Which property of buprenorphine best explains this reaction?
- A.It is a mu-opioid partial agonist that displaces methadone but activates receptors less
- B.It is a full mu-opioid agonist with a much shorter elimination half-life than methadone
- C.Its naloxone component is well absorbed sublingually and then blocks mu-opioid receptors
- D.It is a kappa-opioid agonist that directly produces dysphoria and abdominal cramps
- Case 2
A 29-year-old man newly diagnosed with HIV-1 infection is being considered for an abacavir-containing regimen. Baseline tests: creatinine 80 µmol/L (0.9 mg/dL), ALT normal, HLA-B*5701 positive.
According to the US abacavir label, what is the appropriate action?
- A.Start abacavir at half the usual dose and titrate up over two weeks to induce tolerance
- B.Do not use abacavir; carriers of this allele are at high risk of immune-mediated hypersensitivity
- C.Start abacavir with an oral antihistamine for the first six weeks to prevent the reaction
- D.Start abacavir at the usual dose but check liver enzymes every two weeks for three months
- Case 3
A 64-year-old woman with moderate persistent asthma (budesonide–formoterol) is recovering from a myocardial infarction. Heart rate 92 beats/min, blood pressure 138/84 mmHg. The cardiologist wants to start a beta-blocker while minimising the risk of bronchospasm.
Which agent is the most appropriate choice?
- A.Propranolol
- B.Nadolol
- C.Metoprolol
- D.Carvedilol
